Document Detail


Induction of alkaline phosphatase activity by L-ascorbic acid in human osteoblastic cells: a potential role for CK2 and Ikaros.
MedLine Citation:
PMID:  17664058     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To investigate the effect of L-ascorbic acid (AsA) on osteoblast differentiation, we examined the effects of AsA on in vitro osteoblastic differentiation markers such as collagen synthesis, alkaline phosphatase (ALP) activity, and receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin (OPG) expression. The role of Ikaros and casein kinase 2 (CK2) in regulating osteoblast differentiation was also determined. METHODS: This study examined the expression of RANKL and OPG, collagen synthesis, and ALP activity in AsA-treated osteoblast-like cells (MG63) using reverse transcription-polymerase chain reaction and biochemical assays. In addition, Ikaros activity and CK2 expression were assessed by electrophoretic mobility shift assays and western blot assays, respectively. RESULTS: The results showed that AsA treatment slightly downregulated OPG mRNA expression, whereas the mRNA expression of RANKL and collagen was unaffected. AsA significantly increased ALP activity after 4 d, and this activation was inhibited by the CK2 inhibitors, 2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole and 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazimidazole. Small interfering RNA-mediated depletion of CK2-alpha also decreased ALP activity in AsA-stimulated cells. Moreover, western blot analysis showed that AsA induced the activation of CK2. AsA dose-dependently decreased the DNA binding affinity of the transcription factor Ikaros, which is a bifunctional differentiation factor. Moreover, cells treated with AsA and CK2 inhibitor exhibited increased Ikaros activity compared with those treated with AsA alone. CONCLUSION: These results suggest that AsA stimulates osteoblastic differentiation by enhancing ALP activity and suppressing Ikaros activity. Moreover, this process might be related to CK2 regulation.
Authors:
Eunwha Son; Hang Do; Hae-Mi Joo; Suhkneung Pyo
Related Documents :
11551898 - Osteoclast-stimulating factor interacts with the spinal muscular atrophy gene product t...
18095058 - Steroid and xenobiotic receptor mediates a novel vitamin k2 signaling pathway in osteob...
9794488 - Osteotropic agents regulate the expression of osteoclast differentiation factor and ost...
18434348 - The novel estrogen receptor g-protein-coupled receptor 30 is expressed in human bone.
22988238 - Activation of nf-κb protein prevents the transition from juvenile ovary to testis and ...
10672068 - Recombinant juvenile hormone esterase, an effective tool for modifying juvenile hormone...
Publication Detail:
Type:  Journal Article     Date:  2007-07-30
Journal Detail:
Title:  Nutrition (Burbank, Los Angeles County, Calif.)     Volume:  23     ISSN:  0899-9007     ISO Abbreviation:  Nutrition     Publication Date:  2007 Oct 
Date Detail:
Created Date:  2007-09-17     Completed Date:  2007-12-03     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  8802712     Medline TA:  Nutrition     Country:  United States    
Other Details:
Languages:  eng     Pagination:  745-53     Citation Subset:  IM    
Affiliation:
Department of Herbal Medicine Resource, Institute of Bioscience and Biotechnology, Kangwon National University, Gangwon-do, Republic of Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alkaline Phosphatase / metabolism*
Ascorbic Acid / pharmacology*
Casein Kinase II / genetics*,  metabolism,  physiology
Cell Differentiation / drug effects
Cells, Cultured
Gene Expression Regulation / drug effects
Humans
Ikaros Transcription Factor / genetics*,  metabolism,  physiology
NF-kappa B / metabolism
Osteoblasts / enzymology*,  physiology
Osteoprotegerin / metabolism
RANK Ligand / metabolism*
RNA, Messenger / metabolism
Reverse Transcriptase Polymerase Chain Reaction
Chemical
Reg. No./Substance:
0/IKZF1 protein, human; 0/NF-kappa B; 0/Osteoprotegerin; 0/RANK Ligand; 0/RNA, Messenger; 148971-36-2/Ikaros Transcription Factor; 50-81-7/Ascorbic Acid; EC 2.7.11.1/Casein Kinase II; EC 3.1.3.1/Alkaline Phosphatase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Influence of low-dose polyunsaturated fatty acids supplementation on the inflammatory response of he...
Next Document:  Effect of prebiotic galacto-oligosaccharide, long-chain fructo-oligosaccharide infant formula on ser...